In 1993, the baton of Editor in Chief was passed from Dr. Soffer to Dr. Block, and the success and stature of CHEST continued to grow. Depending on one’s perspective, there are a variety of ways by which the success and quality of medical journals can be measured. These include: circulation; manuscript submissions; quality of publications as reflected by acceptance rate, citation counts, and impact factor2(ie, a measure of the frequency with which the average article in a journal is cited in a particular year); and financial health. From the standpoint of an Editor in Chief, all of these measures are important. During Dr. Block’s tenure, the data show a steady improvement in all over the past 12 years. To ensure that CHEST accepted the best manuscripts received, Dr. Block implemented a policy in which he personally reviewed every manuscript at the completion of the peer review process. At this time, CHEST has: (1) the highest regular annual circulation (eg, 20,450)3 of any respiratory or critical care journal in the world; (2) a rising number of annual manuscript submissions, from 2,080 in 1994, to 2,300 in 2003, to 2,952 in 2004, to a projected number of 3,500 in 2005; (3) a steadily falling annual acceptance rate from 43% in 1993 to 18% in 2004, despite the enormous rise in manuscript submissions; (4) the second highest number of total citations of 31 respiratory journals4; (5) a rising impact factor of 3.114; and (6) an enviable financial performance. Because CHEST enjoys good financial health and is committed to supporting the educational mission of the ACCP, it remains one of the least expensive medical specialty journals; this facilitates its accessibility to subscribers, libraries, and institutions around the globe.